Today in Banking: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Banking.

Press releases published on September 29, 2026

Sep. 29, 2026

ProductLife Group menuntaskan transformasinya menjadi satu grup terpadu dengan kapabilitas manusia dan digital yang menyeluruh di bidang ilmu hayati

Indeterminate GlobeNewswire

Sep. 29, 2026

プロダクトライフ・グループ、ライフサイエンス分野におけるエンドツーエンドの人材およびデジタル能力を備えた、単一の統合グループへの変革を完了

Indeterminate GlobeNewswire

Sep. 29, 2026

ProductLife Group, 생명과학 전반의 엔드투엔드 인적·디지털 역량 갖춘 단일 통합 그룹으로 혁신 완료

Indeterminate GlobeNewswire

Sep. 29, 2026

ProductLife Group menyelesaikan transformasinya menjadi sebuah kumpulan bersepadu yang menawarkan rangkaian lengkap kepakaran tenaga kerja dan keupayaan digital dalam bidang sains hayat

Indeterminate GlobeNewswire

Sep. 29, 2026

ProductLife Group conclui sua transformação em um grupo único e unificado com um conjunto completo de recursos humanos e digitais em ciências da vida

Indeterminate GlobeNewswire

Sep. 29, 2026

ProductLife Group บรรลุการปรับเปลี่ยนองค์กรอย่างสมบูรณ์สู่การเป็นกลุ่มบริษัทเดียว…

Indeterminate GlobeNewswire

Sep. 29, 2026

ProductLife Group 完成转型，整合为统一集团，为生命科学领域提供端到端的人力与数字化能力

Indeterminate GlobeNewswire

Sep. 29, 2026

ProductLife Group 完成轉型為單一統合集團，擁有生命科學領域端到端的人力與數碼能力

Indeterminate GlobeNewswire

Sep. 29, 2026

SoundThinking to be Acquired by Transom Capital Group

Indeterminate GlobeNewswire

Sep. 29, 2026

NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs

Indeterminate GlobeNewswire

Sep. 29, 2026

DeFi Technologies’ Subsidiary Valour Launches Zcash (ZEC) ETP

Indeterminate GlobeNewswire

Sep. 29, 2026

Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)

Indeterminate GlobeNewswire

Sep. 29, 2026

Thérapeutique Knight conclut une entente de distribution exclusive avec Kyowa Kirin International pour Poteligeo® (Mogamulizumab)

Indeterminate GlobeNewswire

Sep. 29, 2026

Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB

Indeterminate GlobeNewswire

Sep. 29, 2026

Kobo Resources Intersects Strong Gold Mineralisation at the Road Cut Zone with 19.0 m at 1.94 g/t Au; Northern Drilling Identifies Potential Areas for Future Resource Growth

Indeterminate GlobeNewswire

Sep. 29, 2026

Ressources Kobo recoupe une importante minéralisation aurifère dans la zone Road Cut, soit 19,0 m à 1,94 g/t Au; Le forage au nord établit des zones potentielles pour la croissance future des ressources

Indeterminate GlobeNewswire

Sep. 29, 2026

StorageVault Announces Repayment at Maturity of its 5.50% Senior Unsecured Hybrid Debentures Due September 30, 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia

Indeterminate GlobeNewswire

Sep. 29, 2026

Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer

Indeterminate GlobeNewswire

Sep. 29, 2026

HPQ and PyroGenesis Close 50/50 Ownership of HPQ Silica Polvere

Indeterminate GlobeNewswire